Respiratory syncytial virus prevention and asthma in healthy preterm infants: A randomised controlled trial
The Lancet Respiratory Medicine Mar 28, 2018
Scheltema NM, et al. - In order to support their previous study, authors continued follow-up and analyzed the impact of respiratory syncytial virus (RSV) prevention during infancy on asthma and lung function at age 6 years. They found that in otherwise healthy preterm infants, RSV prevention did not have a major impact on current asthma or lung function at age 6 years.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
